Table 3.
Best response | T-Cell NHL n, (%)a |
B-Cell NHL n, (%) |
leukemia / myeloma/other n, (%)a |
---|---|---|---|
CR/CRu | 2 (17%) | 0 | 0 |
PRu | 2 (17%) | 1 (9%) | 0 |
SD | 5 (42%) | 2 (18%) | 0 |
PD | 2 (18%) | 8 (73%) | 4 (100%) |
Inevaluableb | 2 | 0 | 1 |
Of evaluable patients
T-Cell: one patient withdrew after Course 1, one patient lost to follow-up; one ALL leukemia patient proceeded to marrow transplant after three courses.